Vetter Pharma International GmbH


Vetter Pharma International GmbH

Established: ​1953

Number of staff: ​Approximately 4,600

Key Personnel: ​Thomas Otto, managing director; Peter Soelkner, managing director


Who we are:

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. Through its U.S. and European facilities, Vetter Development Service provides state-ofthe- art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield.


Major Markets:​ Europe, North America & Asia


Services Offered:

Vetter Development Service ​includes:

–Formulation support

–Process development

–Clinical trial manufacturing

–Analytical service

–Regulatory support


Vetter Commercial Manufacturing ​includes:

–Fill and finish

–Analytical service

–Regulatory support

–Product life cycle management


Vetter Packaging Solutions ​include:

–Customized packaging development

–Specialized technologies

–Proven platform technologies

–Packaging services


Dosage forms:​ Syringes, cartridges and vials

Related resources

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Vetter Pharma

Meeting the challenges of complex drug substances

Vetter Pharma International GmbH | 15-Apr-2014 | Technical / White Paper

Realizing the full potential of an injectable drug compound is no small task. In the months and years that lead from the discovery phase to the rigorous...

Vetter – Answers that work

Vetter – Answers that work

Vetter Pharma International GmbH | 03-Oct-2012 | Data Sheet

There are many sides to your product’s success. Build them together at Vetter.Whether your injectable is still at the starting line or in full-scale production, there...